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Serum cardiac troponins I and T are reliable and highly speciﬁc markers of myocardial injury. Studies have shown that at least
20% of patients with severe aortic stenosis have detectable serum troponins. This case report describes a patient who presented as
suspected acute coronary syndrome with markedly elevated troponin levels, who was later found to have normal coronaries and
critical aortic stenosis. This case highlights the need for comprehensive and accurate physical examination in patients who present
withangina.Criticalaorticstenosismaycausesuchseveresubendocardialischemiaastocausemarkedelevationincardiacmarkers
andmimicanacutecoronarysyndrome.Carefulphysicalexaminationwillleadtoanearlieruseofnoninvasivetechniques,suchas
echocardiographytoconﬁrmthecorrectdiagnosisandtheavoidanceofinappropriatetreatmentssuchasintravenousnitroglycerin
and glycoprotein IIb/IIIa inhibitors.
1.Introduction
In patients with aortic valve stenosis, the development of
left ventricular systolic dysfunction and heart failure predicts
poor prognosis, including a less favorable outcome after
valve replacement [1, 2]. The onset of heart failure is
preceded by structural and functional alterations in the
heart muscle with left ventricular hypertrophy followed by
degeneration and death of the cardiac myocytes [3]. Serum
cardiac troponins I and T are heart speciﬁc contraction-
regulating proteins released into the circulation from injured
myocytes. Their value in acute coronary syndrome is well
known and they are assuming a growing prognostic role in
heart failure as well [4–9]. Critical aortic stenosis (deﬁned
as valve area <0.5mm2)h a sb e e nr e p o r t e dt oc a u s em o d -
est elevations in cardiac biomarkers such as troponin I
[10].
We present an unusual case of critical aortic stenosis that
masqueraded as acute coronary syndrome until deﬁnitive
studies ruled out the latter.
2. Case Presentation
A forty-nine-year-old otherwise healthy Caucasian male
with history of marijuana abuse presented with 12 hours
of constant retrosternal, nonradiating chest pain, partially
relieved by sublingual nitroglycerine. Physical exam was
signiﬁcant for BP 140/74, heart rate 75beats/min, carotid
shudder, single S2, S4 gallop, and a grade IV/VI crescendo-
decrescendo late-peaking murmur in aortic area that radi-
ated to the carotids. These physical examination signs were
consistent with critical aortic stenosis. Laboratory work
revealed a troponin rise from an initial level of 0.09ng/mL
(normal: <0.4ng/mL), CK-MB of 3.7ng/mL (normal: 0–
11.2ng/mL)), to a second troponin value of 26.7ng/mL
which ﬁnally peaked at 99ng/mL (CK-MB of 81.3ng/mL)
within 12–18 hours of presentation. Urine Drug Screen was
negative for cocaine but positive for marijuana. A 12-lead
EKGrevealedsinusrhythmat75beats/minwithleftventricle
hypertrophy and repolarization abnormality (Figure 1)b u t
no acute ST-T changes suggestive of myocardial injury.2 Cardiology Research and Practice
Figure 1: Electrocardiogram showing left ventricle hypertrophy
and repolarization abnormality but no acute ST-T changes sugges-
tive of myocardial injury.
The classic physical exam ﬁndings of aortic stenosis lead
us to an urgent echocardiography, rather than an early
invasive approach of cardiac catheterization. Echocardiog-
raphy revealed (Figure 2)a ne j e c t i o nf r a c t i o no f5 5 – 6 0 % ,
suspected bicuspid aortic valve with critical aortic stenosis
and peak velocity of 5.8m/sec, a peak transvalvular gradient
of 135mm of Hg (mean gradient of 77mm of Hg), and an
i n d e x e dv a l v ea r e ao f0 . 5 2c m 2, all of which were suggestive
of critical aortic stenosis.
Elective coronary angiography done a day later revealed
normal coronaries. The aortic valve could not be crossed.
The patient underwent uncomplicated aortic valve replace-
ment surgery and is doing well.
3. Discussion
Severe aortic stenosis usually causes compensatory left
ventricular hypertrophy. The ventricular hypertrophy may
result in a reduction in coronary vasodilator reserve (CVR),
which is the ratio of maximal to basal coronary blood ﬂow.
CVR can be used as a functional index of the severity
of coronary artery insuﬃciency despite angiographically
normal coronary arteries [11]. A similar reduction in
CVR has also been observed in patients with hypertrophic
cardiomyopathyandhypertension[12].Inthesepatients,the
diastolic perfusion time (DPT) has a signiﬁcant eﬀect on
CVR: the faster the heart rate, the lower the CVR [13]. The
combinationofleftventricularhypertrophy,tachycardia,and
lower perfusion pressure (which can occur in critical aortic
stenosis) will signiﬁcantly impair subendocardial perfusion
resulting in ischemia (Figure 3). Rajappan et al. demon-
strated that there was no obvious relationship between the
degree of hypertrophy and CVR whereas on the other hand
the interaction of DPT and valve area seemed to be the
critical parameter in the development of ischemia in aortic
stenosis [14].
Circulating cardiac troponin I (cTnI) is detectable in
more than one-half and elevated in more than one-ﬁfth of
patients with severe aortic stenosis [15, 16]. Importantly,
cTnI is elevated even in the absence of systolic dysfunction
indicating that it can precede overt LV dysfunction. As per
Nunes et al., serial monitoring of cTnI could help clinicians
identify the start of the inevitable clinical downhill in severe
aortic stenosis [16]. Whether such high levels of troponins
secondary to severe subendocardial ischemia portend poor
prognosis warrants further investigation.
Theusefulnessofanaccurateandthoroughclinicalexam
in the emergency department is of paramount importance
in such patients. Administration of nitrates in the emer-
gency room might have actually worsened this patient’s
subendocardial ischemia. The combination of decreased end
diastolic volume (preload) along with decreased afterload
with nitrate use may have further compromised the eﬀective
stroke volume and thus ischemia.
We were cognizant of the fact that this patient had
a positive urine test for cannabis. Based on the history,
patient last consumed marijuana three weeks prior to
admission. Though there have been few case reports of
cannabis-induced myocardial damage, these cases usually
were associated with recent use of cannabis. On the basis
of a case-crossover analysis that controlled for diﬀerences
between patients, Mittleman et al. found that within 1 hour
after smoking marijuana, the risk of myocardial infarction
onset was elevated 4.8-fold (95% conﬁdence interval, 2.9–
9.5; P<. 001). In the second hour after smoking marijuana,
the relative risk was 1.7 (95% conﬁdence interval, 0.6–
5.1; P = .34), suggesting a rapid decline in the cardiac
eﬀects of marijuana [17]. The risk of ischemic events
is linked to tachycardia and hypertension secondary to
excess sympathetic surge associated with cannabis. How-
ever our patient had heart rate between 70 and 80 and
systolic blood pressures between 140 and 150mm of Hg
at admission. Moreover, the cannabis metabolites persist
in urine for as many as 77 days post abstinence and
hence should not be used as an index of acute ingestion
[18].
4. Conclusion
Extreme elevations in cardiac troponins are rare in the
absence of acute coronary syndromes. This is an unusual
case of critical aortic stenosis presenting as acute coronary
syndrome and highlights the importance of a thorough
physical exam and the early use of noninvasive testing such
as echocardiography. The underlying mechanisms of such
extreme elevation in cardiac biomarkers in patients with
critical aortic stenosis are unclear but could be related
to decreased coronary vasodilator reserve and diastolic
perfusion time. The use of nitrates in the initial triage
for angina may worsen the subendocardial ischemia in
this subset of population and hence should be used with
caution. Finally, since ischemia in this setting is an index
of microcirculatory dysfunction, research is needed to
determine whether the absolute value of troponins cor-
relates with an increased predisposition to systolic dys-
function and a worse prognosis in patients with aortic
stenosis.Cardiology Research and Practice 3
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Figure 2: Echocardiogram showing criteria for critical aortic stenosis.
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Figure 3: Proposed pathophysiology of troponinemia in our
patient with critical aortic stenosis.
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